Sunnatilla Obloyorov

Sunnatilla Obloyorov is the head of the management department of the Pharmaceutical Development Agency in Uzbekistan. In a recent interview, he discussed the ongoing review of reference prices for pharmaceuticals, which is expected to lead to a significant reduction in the prices of over 2,600 medications by 40-60% by the end of 2025. He highlighted the challenges in the current pricing system, particularly the absence of comparable prices for many imported drugs in neighboring countries, which has led to artificial price inflation.